FHLC Among Health Care ETFs
End-of-day Nov 17, 2026 · 33 Health care ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.3% | −2.2% | +4.7% | +3.8% | +19.9% | +22.9% | +56.4% | +42.1% | +216.4% | +324.4% |
| Peer average | −1.2% | −4.0% | +2.1% | −3.2% | +18.2% | +23.3% | +71.2% | +24.1% | +174.3% | — |
| S&P 500 · VOO | −1.0% | −2.4% | −4.5% | −4.5% | +8.3% | +10.2% | +72.7% | +68.0% | +305.1% | — |
$146 of every $1,000 in FHLC is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 14.65% | $1,464.54 | 420K | $601.5M |
| 2 | JNJJohnson & Johnson | Healthcare | 8.69% | $869.17 | 1.3M | $357.0M |
| 3 | ABBVAbbvie | Healthcare | 6.65% | $665.03 | 927K | $273.1M |
| 4 | UNHUnitedhealth Group | Healthcare | 4.78% | $478.15 | 477K | $196.4M |
| 5 | MRKMerck & NEW | Healthcare | 4.56% | $455.94 | 1.3M | $187.3M |
| 6 | TMOThermo Fisher Scientific | Healthcare | 3.28% | $328.31 | 195K | $134.8M |
| 7 | AMGNAmgen | Healthcare | 3.19% | $318.86 | 283K | $131.0M |
| 8 | GILDGilead Sciences | Healthcare | 2.66% | $265.88 | 652K | $109.2M |
| 9 | ABTAbbott Laboratories | Healthcare | 2.39% | $239.17 | 914K | $98.2M |
| 10 | PFEPfizer | Healthcare | 2.10% | $210.20 | 3.0M | $86.3M |
| 11 | ISRGIntuitive Surgical | Healthcare | 1.98% | $198.12 | 186K | $81.4M |
| 12 | DHRDanaher | Healthcare | 1.87% | $187.14 | 334K | $76.9M |
| 13 | VRTXVertex Pharmaceuticals | Healthcare | 1.74% | $174.43 | 133K | $71.6M |
| 14 | —Securities Lending CF | — | 1.74% | $173.67 | 71.3M | $71.3M |
| 15 | 0Y6X.LMedtronic | Healthcare | 1.68% | $168.29 | 672K | $69.1M |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly & | 14.65% |
| 2 | JNJ | Johnson & Johnson | 8.69% |
| 3 | ABBV | Abbvie | 6.65% |
| 4 | UNH | Unitedhealth Group | 4.78% |
| 5 | MRK | Merck & NEW | 4.56% |
| 6 | TMO | Thermo Fisher Scientific | 3.28% |
| 7 | AMGN | Amgen | 3.19% |
| 8 | GILD | Gilead Sciences | 2.66% |
| 9 | ABT | Abbott Laboratories | 2.39% |
| 10 | PFE | Pfizer | 2.10% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 18, 2026 | Sep 22, 2026 | $0.25 |
| Jun 18, 2026 | Jun 23, 2026 | $0.26 |
| Mar 20, 2026 | Mar 24, 2026 | $0.23 |
| Dec 19, 2025 | Dec 23, 2025 | $0.27 |
| Sep 19, 2025 | Sep 23, 2025 | $0.26 |
| Jun 20, 2025 | Jun 24, 2025 | $0.26 |
| Mar 21, 2025 | Mar 25, 2025 | $0.25 |
| Dec 20, 2024 | Dec 24, 2024 | $0.26 |
| Sep 20, 2024 | Sep 24, 2024 | $0.25 |
| Jun 21, 2024 | Jun 25, 2024 | $0.24 |
| Mar 15, 2024 | Mar 20, 2024 | $0.24 |
| Dec 15, 2023 | Dec 20, 2023 | $0.22 |